Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria

Liang, Sydney E.; Hoffmann, Rachel; Peterson, Erik; Soter, Nicholas A.

doi:10.1001/jamadermatol.2018.3715

Cited by 30 publications

(14 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Immunotherapy is considered as a third line therapy and could be tried in patients with severe refractory autoimmune urticaria. Various immunosuppressants that have been tried in severe chronic urticaria include cyclosporine, methotrexate, sulphasalazine, dapsone, cyclophosphamide, and intravenous immunoglobulin [3][4][5][6][7][8]. In a recent placebo controlled study autohaemotherapy has shown a beneficial role in ASST positive chronic urticaria patients [9].…”

Section: Resultsmentioning

confidence: 99%

Oral mini-pulse steroid therapy in severe chronic urticaria

Keen¹,

Shah²

2021

Our Dermatol Online

View full text Add to dashboard Cite

Background: Treatment of chronic urticaria can be difficult at times. The present study aimed to evaluate the efficacy of oral mini-pulse (OMP) therapy with methylprednisolone in management of severe chronic urticaria (CU). Methods and material: 100 patients with severe chronic urticaria, not controlled with maximum dose of a second generation antihistamine, were enrolled in the study after an informed written consent. All patients were treated with methylprednisolone 16 mg tablet on two consecutive days of a week for 2 months along with levocetirizine 5 mg tablet once daily. All patients were reviewed at 0, 2, 4, and 8 weeks with urticaria activity score (UAS). Results: The study comprised of 100 patients (33 males and 67 females) with severe chronic urticaria. 29 patients (29%) had raised TSH levels while Autologous Serum Skin Test was positive in 37 patients. Mean UAS in patients treated with OMP was 5.76 at baseline which reduced to 0.6 at the end of treatment period. Conclusion: Mean UAS showed a significant decline following OMP therapy with methylprednisolone. Most of the patients maintained the benefits of therapy at the end of follow up period of 4 months.

show abstract

Section: Resultsmentioning

confidence: 99%

Oral mini-pulse steroid therapy in severe chronic urticaria

Keen¹,

Shah²

2021

Our Dermatol Online

View full text Add to dashboard Cite

show abstract

“…Dapsone was reported to be effective in several types of chronic urticaria and angioedema. In using dapsone to treat a skin disorder, a physician might start on a low dose of dapsone and gradually adjust the treatment dose to control the skin disease [ 81 ]. Dosage is based on the patient’s medical condition and response to treatment.…”

Section: Treatments Of Itch In Children and Adolescencementioning

confidence: 99%

“…These are rare but serious side effects, requiring close monitoring. Since the standardized age of use of these immunomodulators has not been well established, additional studies for proving long-term safety would be helpful [ 71 , 81 ].…”

Section: Treatments Of Itch In Children and Adolescencementioning

confidence: 99%

Differential Diagnosis and Treatment of Itching in Children and Adolescents

Kang

Chung

et al. 2021

Biomedicines

View full text Add to dashboard Cite

Itching is prevalent in children with skin disorders and associated with effects on their mood, quality of life, and social functioning. Surprisingly, there are no data on childhood prevalence of pruritus in the general population. The aim of this article is to explore the epidemiology, clinical manifestation, and treatment for itch (pruritus) in the pediatric population (from infancy to adolescence), and to be helpful to primary care physicians who assess and diagnose pediatric patients with itching. In this study, we searched for specific keywords using PubMed and MEDLINE (Ovid) and, then, refined the retrieved searches for each cause and treatment. As a result of reviewing the literature, atopic dermatitis was shown to be the most common cause of itching, especially during infancy and through preschool. Not only skin disorders but also systemic diseases, drugs, and postburn states can predispose an individual to itching in childhood. There are traditional and newly developed treatment modalities for itching in pediatric patients. However, because the pharmacokinetics and pharmacodynamics of childhood are different from those of adults, the medications for itching have to be applied carefully for these age groups. There are many areas to be elucidated regarding the prevalence and objective assessment of pruritus in pediatric patients. Moreover, the safety profiles of medications in the pediatric population need to be better understood. Further studies to investigate itching in childhood are warranted.

show abstract

“…O mecanismo de ação na UCE não foi totalmente esclarecido, entretanto, os efeitos anti-inflamatórios da dapsona abrangem uma variedade de possíveis propriedades relevantes na urticária. Estas incluem interferência com a liberação ou função de enzimas lisossomais e com a geração de mieloperoxidase, mas, também interferência com a adesividade de neutrófilos mediada por integrina e inibição da atividade de prostaglandinas e leucotrienos 36,38,39 .…”

Section: Dapsonaunclassified

Tratamento da UCE refratária aos anti-histamínicos e na impossibilidade do omalizumabe, nos adultos

Gehlen

Mousinho-Fernandes²,

Argolo³

et al. 2021

AAAI

View full text Add to dashboard Cite

Há o empenho contínuo de especialistas no desenvolvimento de tratamentos resolutivos ou eficazes nos controles das doenças, no entanto, a entidade urticária crônica espontânea (UCE), quando refratária à primeira linha de tratamento, os anti-histamínicos, apresenta um prognóstico desfavorável. Existe um arsenal de medicamentos biológicos disponíveis já consolidados como eficazes e seguros, porém eventualmente nos defrontamos com a inacessibilidade a estes medicamentos, devido aos custos dos mesmos e aos trâmites necessários para dar início ao tratamento. Tais fatos fundamentam a discussão sobre terapias alternativas com outros fármacos, visando manter o manejo adequado da doença e a qualidade de vida dos pacientes.Descritores: Urticária, imunossupressores, ciclosporina.Specialists have made a continuous effort for the development of effective treatments for disease control; however, chronic spontaneous urticaria (CSU), when refractory to the first line of treatment, ie, antihistamines, has an unfavorable prognosis. There are biological medicines available, which have been consolidated as effective and safe, but we are occasionally faced with a lack of access to these medicines due to their costs and the necessary procedures to start treatment. Such facts support the discussion about alternative therapies with other drugs, aiming at maintaining the adequate management of the disease and the quality of life of patients.

show abstract

Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria

Cited by 30 publications

References 19 publications

Oral mini-pulse steroid therapy in severe chronic urticaria

Oral mini-pulse steroid therapy in severe chronic urticaria

Differential Diagnosis and Treatment of Itching in Children and Adolescents

Tratamento da UCE refratária aos anti-histamínicos e na impossibilidade do omalizumabe, nos adultos

Contact Info

Product

Resources

About